Neoadjuvant chronomodulated capecitabine with radiotherapy in rectal cancer: a phase II brunch regimen study

Akgun Z., Saglam S., YÜCEL S., Gural Z., Balik E., Cipe G., ...Daha Fazla

CANCER CHEMOTHERAPY AND PHARMACOLOGY, cilt.74, sa.4, ss.751-756, 2014 (SCI-Expanded) identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 74 Sayı: 4
  • Basım Tarihi: 2014
  • Doi Numarası: 10.1007/s00280-014-2558-x
  • Dergi Adı: CANCER CHEMOTHERAPY AND PHARMACOLOGY
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Sayfa Sayıları: ss.751-756
  • Anahtar Kelimeler: Chronomodulated chemotherapy, Capecitabine, Neoadjuvant chemoradiotherapy, Rectal cancer, METASTATIC COLORECTAL-CANCER, DIHYDROPYRIMIDINE DEHYDROGENASE, PREOPERATIVE RADIOTHERAPY, RADIATION-THERAPY, FOLINIC ACID, CHEMOTHERAPY, FLUOROURACIL, OXALIPLATIN, PHARMACOKINETICS, COMBINATION
  • Acıbadem Mehmet Ali Aydınlar Üniversitesi Adresli: Evet

Özet

The aim of this study was to evaluate efficacy and safety of chronomodulated capecitabine administered according to a specific time schedule (Brunch Regimen: Breakfast and Lunch) as a part of neoadjuvant chemoradiation therapy in patients with locally advanced rectal cancer.